Abstract
Breast cancer activism has become a fixture in the United States, where fundraising events are ubiquitous and government financing of research into the disease has skyrocketed. Activists in other countries are now reporting similar accomplishments. Here, predominantly using the United States as a case study, I analyse the recent successes of breast cancer activism. I also raise a series of questions about the future goals of activism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lerner, B. H. The Breast Cancer Wars: Hope, Fear and the Pursuit of a Cure in Twentieth–Century America (Oxford Univ. Press, New York, 2001).
Lasser, T. Reach to Recovery (Simon & Schuster, New York, 1972).
Seaman, B. The Doctors' Case against the Pill (Peter H. Wyden, New York, 1969).
Boston Women's Health Book Collective. Our Bodies, Ourselves: a Book for and by Women (Simon and Schuster, New York, 1973).
Klemesrud, J. New voice in debate on breast surgery. New York Times 56 (12 December, 1972).
Kushner, R. Breast Cancer: a Personal and an Investigative Report (Harcourt Brace Jovanovich, New York, 1975).
Fisher, B. The revolution in breast cancer surgery: science or anecdotalism? World J. Surg. 9, 655–666 (1985).
Casamayou, M. H. The Politics of Breast Cancer (Georgetown Univ. Press, Washington DC., 2001).
Lerner, B. H. No shrinking violet: Rose Kushner and the rise of American breast cancer activism. West. J. Med. 174, 362–365 (2001).
Reagan, L. J. Engendering the dread disease: women, men and cancer. Am. J. Public Health 87, 1779–1787 (1997).
Belkin, L. How breast cancer became this year's hot charity. New York Times Magazine 40–57 (22 December, 1996).
Waller, M. & Batt, S. Advocacy groups for breast cancer patients. Can. Med. Assoc. J. 152, 829–833 (1995).
Steimle, S. Europa Donna unites Europe against breast cancer. J. Natl Cancer Inst. 88, 1614–1615 (1996).
Hedenfalk, I. et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539–548 (2001).
Bazell, R. Her-2: the Making of Herceptin, a Revolutionary Treatment for Breast Cancer (Random House, New York, 1998).
Fernandez, M. E. et al. Evaluation of ENCORE plus: a community-based breast and cervical cancer screening program. Am. J. Prev. Med. 16, 35–49 (1999).
Ruzek, S. B. & Becker, J. The women's health movement in the United States: from grass-roots activism to professional agendas. J. Am. Med. Womens Assoc. 54, 4–8, 40 (1999).
Institute of Medicine. Scientific Opportunities and Public Needs: Improving Priority Settings and Public Input at the National Institutes of Health (National Academy Press, Washington DC., 1998).
Greenlee, R. T., Hill-Harmon, M. B., Taylor, M. & Thun, M. Cancer statistics, 2001. CA Cancer J. Clin. 51, 15–36 (2001).
Ready, T. Little sympathy for ex-smokers. Los Angeles Times S1 (26 March, 2001).
Hurst, L. With little attention lung cancer just keeps on killing. Toronto Star A1 (16 June, 2001).
Kalb, C., Wingert, P. & Foote, D. Stars, money and medical crusades. Newsweek 58 (22 May, 2000).
Olsen, O. & Gøtsche, P. C. Cochrane review on screening for breast cancer with mammography. Lancet 358, 1340–1342 (2001).
Kolata, G. Study sets off debate over mammograms' value. New York Times A1 (9 December, 2001).
Welch, G. H. Questions about the value of early intervention. N. Engl. J. Med. 334, 1472–1473 (1996).
Howe, H. L. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl Cancer Inst. 93, 824–842 (2001).
Canadian Cancer Statistics. (National Cancer Institute of Canada, Toronto, 2001).
Nelson, N. J. Research seeks links between cancer, gene-environment interactions. J. Natl Cancer Inst. 92, 1121–1123 (2000).
Fagin, D. Clinton holds cancer hearing: L. I. activists skeptical of progress. New York Newsday A7 (12 June, 2001).
Brenner, B. A. A new focus for cancer stamps. Boston Globe A23 (21 July, 2000).
Leopold, E. A Darker Ribbon: Breast Cancer, Women, and Their Doctors in the Twentieth Century. (Beacon Press, Boston, 1999).
Epstein, S. S. The Politics of Cancer Revisited (East Ridge Press, New York, 1998).
Kasper, A. S. & Ferguson, S. J. in Breast Cancer: Society Shapes an Epidemic (eds Kasper, A. S. & Ferguson, S. J.) 355–373 (St Martin's Press, New York, 2000).
Steingraber, S. Mechanisms, proof, and unmet needs: the perspective of a cancer activist. Environ. Health Perspect. 105, 685–687 (1997).
Cornacchia, C. Toxin avengers: not satisfied with waiting for research to find a breast-cancer cure, many who suspect the tainted environment are pushing for action. Montreal Gazette E1 (25 October, 1999).
Stellman, S. D. et al. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol. Biomarkers Prev. 9, 1241–1249 (2000).
Wolff, M. S. et al. Risk of breast cancer and organochloride exposure. Cancer Epidemiol. Biomarkers Prev. 9, 271–277 (2000).
Key, T. J. et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br. J. Cancer 81, 1248–1256 (1999).
Fisher, B. et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J. Natl Cancer Inst. 90, 1371–1388 (1999).
Norsigian, J. et al. Re: weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J. Natl Cancer Inst. 92, 757–758 (2000).
Berman, L. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet 356, 881–887 (2000).
Powles, T. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 352, 98–101 (1998).
Brenner, B. STARs in their eyes. Newsletter of Breast Cancer Action Vol. 55 (August–September, 1999).
Rubin, R. Tamoxifen marker ordered to back off breast cancer claims. USA Today 10D (8 August, 2000).
Zones, J. S. Strangers in our own land. Newsletter of Breast Cancer Action 67, 5 (September–October, 2001).
Cornacchia, C. Victims of our own success, breast-cancer activist says. Montreal Gazette A12 (29 July, 1999).
Leopold, E. Shopping for the cure. The Prospect (24 September–2 October, 2000).
Zones, J. S. in Breast Cancer: Society Shapes an Epidemic (eds Kasper, A. S. & Ferguson, S. J.) 119–151 (St Martin's Press, New York, 2000).
Acknowledgements
The author is a Robert Wood Johnson Foundation Generalist Physician Faculty Scholar and an Angelica Berrie-Arnold P. Gold Foundation Scholar. The author thanks S. Batt for her advice and V. Kiesig for research assistance.
Author information
Authors and Affiliations
Related links
Related links
DATABASES
FURTHER INFORMATION
Boston Women's Health Book Collective
Canadian Breast Cancer Network
National Alliance of Breast Cancer Organizations
National Breast Cancer Coalition
National Women's Health Network
Reach to Recovery International
LINKS
Rights and permissions
About this article
Cite this article
Lerner, B. Breast cancer activism: past lessons, future directions. Nat Rev Cancer 2, 225–230 (2002). https://doi.org/10.1038/nrc744
Issue Date:
DOI: https://doi.org/10.1038/nrc744